The Division of Cancer Biology studies the complex interplay of genes, proteins and biological processes that drive the development and growth of cancers. Understanding the many different biological ...

The Generations Study is a longitudinal cohort study that collects extensive high-quality data to study the continuum of breast cancer.

We are currently advertising one fully-funded PhD project and the application deadline is Sunday 1st September 2024. Below you will find a link to further information about our application process, ...

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found.

Yvonne Diaz, 55, was diagnosed with stage 4 ALK-positive lung cancer in August 2021. She works in Communications and lives in Holland Park, London with her husband and twin sons, aged 17.

"More research into pancreatic cancer is desperately needed as survival hasn't improved in decades." Michael Parry was diagnosed with pancreatic cancer at the age of 59. His cancer was detected early ...

Professor Andrea Sottoriva obtained his BSc in computer science from the University of Bologna in 2006 and his MSc in computational modelling from the University of Amsterdam in 2008. While attending ...

Professor Amy Berrington is an expert in the use of real world data to study the late-effects of cancer treatments, medical radiation exposures and other medications and is leading major studies in ...

Professor Gail ter Haar is investigating the use of high intensity focused ultrasound (HIFU) to rapidly heat and kill tumours of the liver or kidney. Gail is founding President of the International ...

Dr Rachael Natrajan is researching the ways in which different subgroups of breast cancer can be characterised through genetic analysis of the tumour. By improving this understanding, it is hoped that ...

Immunotherapy together with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers, promising early results from a Phase I trial suggest. Two of the ...